Dark Forest Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Other funds holding RETA
CI
EC
CCM
BC
Dark Forest Capital Management's RETA Position: Q1 2022 in Review
Dark Forest Capital Management sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q1 2022, closing a stake of 206 shares — an estimated $5K sold.
Dark Forest Capital Management first reported a position in RETA in Q3 2021 and held it in 2 quarters. The position peaked at $5K in Q4 2021. 149 funds tracked by Wall St. Rank hold RETA as of Q1 2022.
- Dark Forest Capital Management reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
- Dark Forest Capital Management sold 206 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q1 2022, an estimated $5K.
- Dark Forest Capital Management first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2021 and held it in 2 quarters.
- Dark Forest Capital Management's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $5K in Q4 2021.
- 149 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q1 2022.
Based on Dark Forest Capital Management's 13F filing for Q1 2022, filed 13 May 2022.